| Financial Year |
March 31 2023 |
| Monetary Funds |
100,880,309.11 |
| Held-for-trading Financial Assets |
74,864,599.38 |
| Notes Receivable |
14,366,427.43 |
| Accounts Receivable |
162,564,116.54 |
| Advances to Suppliers |
3,769,810.50 |
| Other Receivables |
1,118,086.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
64,885,068.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
493,273,567.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
9,728,826.86 |
| Fixed Assetes |
182,984,452.11 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
24,405,616.20 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
294,605.57 |
| Deferred Income Tax Assets |
1,928,005.59 |
| Other Non-Current Assets |
2,395,600.00 |
| Sub-Total of Non-Current Assets |
226,435,159.21 |
| Total Assets |
719,708,726.35 |
| Short-Term Loans |
59,637,889.13 |
| Trading Financial liabilities |
-- |
| Notes Payable |
38,913,593.19 |
| Accounts Payable |
36,239,598.81 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,007,462.35 |
| Taxes Payable |
5,228,614.71 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
672,177.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,776,798.34 |
| Other Current Liabilities |
797,480.74 |
| Sub-Total of Current Liabilities |
160,359,464.03 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
146,138.42 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,874,366.95 |
| Total Liabilities |
164,233,830.98 |
| Paid-In Capital(Or Share Stock) |
133,340,000.00 |
| Capital Surplus |
173,804,736.99 |
| Surplus Reserve |
44,095,320.03 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
204,234,838.35 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
555,474,895.37 |
| Owner's Equity（Stockholder's Equity） |
555,474,895.37 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
719,708,726.35 |
